baber/WOPTO huggingface dataset:
Patent NZ-532673-A (NZ)
Title: Package comprising a medicament, a component that gradually releases a gaseous substance and an adsorbent material
Inventor: BARKER FRANK
IPC: A61M15/00
Filed: 2002-11-15
Abstract: Use of an absorbent in preventing the formation of an adduct in a pharmaceutical product due to a chemical reaction between the medicament and a gaseous substances in the product.
Patent NZ-537629-A (NZ)
Title: Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2A receptor-related disorders
Inventor: NILSSON BJORN
IPC: A61P25/16
Filed: 2003-06-25
Abstract: Disclosed are novel piperazinyl-pyrazinone derivatives of formula (I) and methods of making them wherein: m is 1 or 2 n is 0, 1, 2, 3 or 4; R1 is H, alkyl, aryl-alkyl, heteroaryl-alkyl, 2-hydroxyethyl, methoxy-alkyl, alkyoxycarbonyl, aryloxy-alkyl or heteroaryloxy-alkyl; R2 and R3 each independently represent H or CH3; R4 and R5 each independently represent H, halogen, methyl, or together with the ring to which carbon atoms they are attached, form a 1H-quinoxalin-2-one nucleus; and R6 represents aryloxy, heteroaryloxy, arylthio, heteroarylthio, aryl-NH, heteroaryl-NH, aryl, aryl carbonyl, heteroaryl, or heteroarylcarbonyl. Compounds of the type disclosed are useful in the treatment of 5-HT2A receptor related disorders.
Patent NZ-538566-A (NZ)
Title: Imidazopyridines as cyclin dependent kinase inhibitors
Inventor: DWYER MICHAEL P
IPC: C07D471/04
Filed: 2003-09-17
Abstract: Disclosed is a class of imidazo[1,2-a]pyridine compounds of formula III as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and prevention, inhibition, or amelioration of one or more diseases associated with cyclin dependent kinases using such compounds or pharmaceutical compositions. The compounds are useful as protein kinase inhibitors in diseases such as cancer, inflammation arthritis, viral diseases, neurodegenerative diseases such as Alzheimer's disease, cardiovascular diseases, and fungal diseases.
Patent NZ-538850-A (NZ)
Title: Services duct assembly
Inventor: SIMS DAVID JOHN
Filed: 2005-03-14
Abstract: A duct assembly, for services, includes a duct having a channel with a base and an open side. A detachable lid 4 is provided for closing the open side, along with at least one fascia 5. The base of the assembly can be attached to a connection surface 3, such as a wall or floor, and the fascia 5 is shaped such that when it is attached to the duct, it is also in contact with the connection surface 3.
Patent NZ-541694-A (NZ)
Title: Nogo receptor-mediated blockade of axonal growth
Inventor: STRITTMATTER STEPHEN M
IPC: C07K14/705
Filed: 2001-01-12
Abstract: An in vitro method of promoting neurite outgrowth comprising contacting a neuron with a Nogo receptor (NgR) antagonist which is selected from the group consisting of an isolated NgR polypeptide and an antibody or antigen binging fragment thereof that binds a NgR polypeptide. The NgR antagonist inhibits CNS myelin-induced neurite outgrowth inhibition and can also be used in the preparation of a medicament to treat a CNS disease.
Patent NZ-541902-A (NZ)
Title: Pyrimidine derivatives for the prevention of HIV infection
Inventor: HEERES JAN
IPC: A61P31/18
Filed: 2004-02-04
Abstract: The disclosure relates to the use of a pyrimidine derivative compound of formula (I) for the manufacture of a medicament for the prevention of HIV infection via sexual intercourse or related intimate contact between partners, wherein the medicament is in a form adapted to be applied to the body site where the sexual intercourse or related intimate contact between partners takes place, and wherein the variables shown in formula (I) are as defined in the specification.
Patent NZ-545415-A (NZ)
Title: Stable crystalline form of bifeprunox mesylate (7-[4-([1,1'-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate
Inventor: ZWIER KLAAS
IPC: A61P25/16
Filed: 2004-08-18
Abstract: The disclosure relates to a stable polymorphic crystalline form of the compound 7-[4-([1,1'-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate (INNM bifeprunox mesylate), a method for the preparation of said polymorphic form and its use in pharmaceutical products, especially in pharmaceutical products for the treatment of CNS disorders such as psychotic disorders and Parkinson's disease.
Patent NZ-552670-A (NZ)
Title: Tricyclic pyrazole derivatives as cannabinoid receptor modulators
Inventor: LOHRAY BRAJ BHUSHAN
IPC: C07D495/14
Filed: 2005-07-08
Abstract: The present disclosure relates to novel tricyclic pyrazole compounds of general formula (I), wherein the substituents are defined in the specification and their pharmaceutically acceptable salts, novel intermediates involved in their synthesis. Also disclosed is a process of preparing compounds of general formula (I), pharmaceutical compositions containing them, methods of treatment of non-human mammals using said compounds, the use of said compounds in the manufacture of a medicament for the treatment of disorders related to cannabinoid receptors and novel intermediates involved in their synthesis.
Patent NZ-553098-A (NZ)
Title: Methods for identifying factors for differentiating definitive endoderm
Inventor: D AMORE KEVIN ALLEN
IPC: C12N5/0735
Filed: 2005-06-23
Abstract: Disclosed is a method of identifying a differentiation factor capable of promoting the differentiation of human definitive endoderm cells in a cell population comprising human cells, said method comprising the steps of: providing a cell population comprising human definitive endoderm cells, wherein said human definitive endoderm cells comprise at least 10% of the human cells in said cell population; providing a candidate differentiation factor to said cell population; determining expression of a marker in said cell population at a first time point; determining expression of the same marker in said cell population at a second time point, wherein said second time point is subsequent to said first time point and wherein said second time point is subsequent to providing said cell population with said candidate differentiation factor; and determining if expression of the marker in said cell population at said second time point is increased or decreased as compared to the expression of the marker in said cell population at said first time point, wherein an increase or decrease in expression of said marker in said cell population indicates that said candidate differentiation factor is capable of promoting the differentiation of said human definitive endoderm cells.
Patent NZ-553810-A (NZ)
Title: A nozzle which pivots between two positions for dosing of a material from a container
Inventor: HJORT FINN HOLME
IPC: B05C17/005
Filed: 2005-09-06
Abstract: A nozzle (1) for use in connection with the dosing of a material from a container is disclosed. The nozzle includes a first nozzle base part (2), a nozzle tip part (3), and a link (4) connecting the nozzle parts. The link has a first pivotal state and a second locked state when the link is under pressure by the material flow. The link includes a first surface and a second surface. The surfaces are pivotally connected to each other and the surfaces are angled in relation to the longitudinal centre axis of the nozzle. In a first position of the first nozzle base part and nozzle tip part, the first nozzle base part and nozzle tip part form a conical internal flow channel, where no part of the link protrudes into the conical internal flow channel.
Patent NZ-561646-A (NZ)
Title: Tuning using control signals generated by a resistive network ladder using quasi-orthoganal polynomial functions
Inventor: ROKOS GEORGE HEDLEY STORM
IPC: H03B5/12
Filed: 2005-10-17
Abstract: Disclosed is a tuning arrangement for a resonant circuit, the tuning arrangement comprising: an array of tuning circuits connected in a network and means for generating a plurality of control signals. The network has an output reactance dependent upon a plurality of input applied signals one of which is an input tuning signal, the output reactance being used to control the resonance frequency of the resonant circuit. Each tuning circuit has a control input and has a reactance which varies in dependence upon the value of the control signals, which are applied to the control input. The control signal for each circuit varies linearly with the input tuning signal through a predetermined range specific to that control signal so that the frequency response of the resonant circuit to the input tuning signal is linear throughout a desired range of the input tuning signal. The means for generating control signals comprises a resistive network in the form of a ladder, with the input applied signals applied to the top and bottom of the ladder, and the control signals are derived from the potentials on one side of the ladder. The resistances in the ladder are arranged such that the proportions of the individual input applied signals that are derived at the control inputs result in the creation of adjustments to the tuning response that are polynomial functions of the input tuning signal level. These functions are quasi-orthogonal functions of the third order or less for input applied signals that are independent of the input tuning signal, and application of input applied signals that are dependent on the input tuning signal to the top and bottom of the ladder results in a modification to the tuning response that has a power dependency that is of the fourth order. The tuning response to the input tuning signal can be adjusted and set to be substantially linear.
Patent NZ-566950-A (NZ)
Title: Basket style carrier with rigid medial beam and reinforced end handles
Inventor: BATES AARON L
IPC: B65D5/468
Filed: 2008-03-26
Abstract: A basket style carrier is disclosed comprising: a bottom wall; a pair of opposed side walls; a pair of opposed end walls, each comprising: a pair of side end flaps each having a corner aperture at least partially defined therein, each of the pair of side end flaps being hingedly connected to a respective one of the side walls, the pair of side end flaps extending towards one another such that the distal ends thereof abut one another to join the respective corner apertures, thereby at least partially defining a slot handle; and a medial beam extending between the end walls; and a composite partition connected to and extending inwardly from each of the end walls, each of the composite partitions being connected to the medial beam.
Patent NZ-569204-A (NZ)
Title: Pharmaceutical compositions with resistance to soluble CEA - comprising antibodies that bind to CD3 and CEA
Inventor: LUTTERBUSE RALF
IPC: C07K16/30
Filed: 2006-12-21
Abstract: Disclosed is a bispecific single chain antibody which has (a) a first binding domain specifically binding to human CD3, and (b) a second binding domain specifically binding to human CEA. The antibody is adapted for the treatment of progressive tumors, late stage tumors, tumor patients with high tumor load/burden, metastatic tumors, or tumor patients with a CEA serum concentration higher than 100 ng/ml.
Patent NZ-570145-A (NZ)
Title: Computer system for DNA matching
Inventor: BILL MARTIN
IPC: G16B30/00
Filed: 2007-02-02
Abstract: A computer system for searching a computer database containing stored DNA profiles. The system is able to: - Obtain a search profile by analysing a DNA containing sample and generating a search profile. The search profile is formed from two or more allele identities for each loci. The allele identities have a value or a limited range of values or any value, with at least one of the allele identities having a limited range of values. The 'value' is an expression or allele size of allele designation; - Access the stored DNA profiles from the computer database; - Compare the search profile against the stored DNA profiles; - Establish that the search profile matches a stored DNA profile when, in respect of a locus, the allele identities of the search profile correspond to or fall within the values for the allele identities for the locus of the stored DNA profile; - Output a data set indicating those of the stored DNA profiles established as matching the search profile. The system is suitable for application in forensic science and paternity testing.
Patent NZ-570866-A (NZ)
Title: Merging multi-line log entries
Inventor: AGUILAR-MACIAS HECTOR
IPC: G06F13/00
Filed: 2007-04-03
Abstract: A method for merging multiple log entries received by a data processing system comprising: - receiving multiple log entries; - for each received log entry: determining if the log entry contains an ID common to any potential merged event in accordance with merge properties; beginning a new merged event, if the log entry is a beginning log entry of a merged event in accordance with the merge properties; ending an existing merged event, if the log entry is an ending log entry of an existing merged event in accordance with the merge properties; and mapping each log entry containing an ID common to an existing merged event to that merged event in accordance with mapping properties for the merged event.
Patent NZ-574054-A (NZ)
Title: Method of water dispersing pregelatinized starch in making gypsum products
Inventor: YU QIANG
IPC: B32B13/00
Filed: 2007-04-06
Abstract: The disclosure relates to a gypsum-containing slurry including stucco and an aqueous pre-dispersion of a pregelatinized starch. Also provided is a method of making gypsum wallboard by providing a pre-dispersion of the pregelatinized starch in water, and adding the pregelatinized starch pre-dispersion to the gypsum-containing slurry. The pregelatinized starch can have a particle size distribution within the following range: d (0.1) = about 20 microns - 35 microns, d (0.5) = about 60 microns - 110 microns, d (0.9) = about 100 microns - 220 microns.
Patent NZ-579555-A (NZ)
Title: Automated evisceration apparatus having arm with scoop which grips viscera and drops into a receptacle
Inventor: WALKER BRENT MAITLAND
IPC: A22B5/00
Filed: 2010-11-17
Abstract: An apparatus for the automated evisceration of carcasses 2, particularly of larger animals such as sheep or cattle, includes a robot actuator 7 which moves an arm and a scoop 12, 13 on the end of the arm. The scoop includes a first contacting surface 3 and a second contacting surface 10. As the actuator moves the scoop on the end of the arm into the thoracic cavity to eviscerate the carcass the first contacting surface 3 of the scoop abuts the walls of the thoracic cavity and engages with the viscera attached to the cavity wall, and as the scoop moves down the cavity adjacent the cavity wall, the second contacting surface 10 contacts or at least partially surrounds the protuberant portion of the spine of the carcass to frictionally engage with and detach the viscera from the carcass. The detached viscera is scooped from the carcass cavity in the scoop and deposited in a tray 6 below the head of the upside down hanging carcass.
Patent NZ-583314-A (NZ)
Title: Metal can having radiation-curable package coating and method of making the packaging
Inventor: BARTLEY MICHAEL
IPC: B65D23/00
Filed: 2008-07-29
Abstract: Disclosed herein is a metal can coated at least in part with a composition comprising: i) a polyene comprising (meth)acrylate and ii) ii) a polythiol, wherein the composition is curable by radiation such as ultraviolet UV light. Also disclosed is a method for making a package comprising a) coating a metal can, at least in part, with a composition defined above, and exposing the composition to radiation.
Patent NZ-588181-A (NZ)
Title: Idebenone for the treatment of respiratory illness in muscular dystrophy
Inventor: BUYSE GUNNAR
IPC: A61P11/00
Filed: 2009-04-03
Abstract: Provided is the use of idebenone for the manufacture of a medicament for the prophylaxis and/or treatment of respiratory illness in muscular dystrophy. Further provided are suitable formulations and dosages and combinations with glucocorticosteroids.
Patent NZ-589287-A (NZ)
Title: Administrable compositions
Inventor: HAWKETT BRIAN STANLEY
IPC: A61K9/10
Filed: 2009-05-15
Abstract: A composition comprising pharmacologically acceptable particulate material dispersed throughout a pharmacologically acceptable liquid carrier, the particulate material being maintained in the dispersed state by a steric stabiliser, wherein the steric stabiliser is a block copolymer having a number average molecular weight ranging from about 1,000 to about 3,000 comprising a steric stabilising polymeric segment, such as polyacrylamide, polyethylene oxide, polyhydroxyethylacrylate, poly N-isopropylacrylamide, polydimethylamino, ethylmethacrylate or polyvinyl pyrrolidone, and an anchoring polymeric segment, one or both of which are derived from one or more ethylenically unsaturated monomers that have been polymerised by a living polymerisation technique, wherein the steric stabilising polymeric segment is different from the anchoring polymeric segment, and wherein the anchoring polymeric segment has an affinity toward the surface of the particulate material and secures the stabiliser to the particulate material. The composition is used for hyperthermia treatment and in a process of obtaining a diagnostic image.
Patent NZ-591919-A (NZ)
Title: Oil-in-water emulsions comprising a polymeric surfactant and water-insoluble active agent for application to skin or vaginal mucosa
Inventor: MURA EMANUELA
IPC: A61K9/00
Filed: 2009-09-21
Abstract: Disclosed is an oil in water emulsion containing (i) an internal hydrophobic phase containing benzyl alcohol and 2-octyldodecanol, (ii) an external hydrophilic phase containing lower alkanols, polyhydric alcohols, polyethylene glycols, polypropylene glycols or mixtures thereof, (iii) at least a polymeric surfactant selected from the group of acrylates/C10-C30 alkyl acrylate crosspolymers and/or cellulose ethers, (iv) at least a water insoluble active principle selected from anti-bacterial drugs, anti-fungal drugs, anti-protozoal drugs, anti-inflammatory drugs and hormones; wherein said emulsion does not contain neutralising agents. The emulsion is useful for treating a vaginal inflammation or infection of bacterial, fungal or protozoal origin.
Patent NZ-593688-A (NZ)
Title: Micrornas that regulate muscle cell proliferation and differentiation
Inventor: CHEN JIANFU
IPC: C12N15/113
Filed: 2006-12-12
Abstract: Disclosed is the use of an effective amount of miR-206 or a vector encoding miR-206 in the manufacture of a medicament for the treatment of muscle injury in a subject.
Patent NZ-596149-A (NZ)
Title: Box with foldable and demountable outer walls including shaft and cam arrangement at base
Inventor: ORGELDINGER WOLFGANG
IPC: B65D6/18
Filed: 2010-04-14
Abstract: A foldable box comprising a base having an rigid outer side area which extends from the base upwardly in the vertical direction, in addition to an outer side (6b) comprising a shaft (50) which is arranged in the base area of the outer side. The foldable box also comprises a guide opening in the rigid outer side area comprising the shaft, the guide opening comprising an opening section which extends essentially in the vertical direction and through which the shaft can be guided out from and a lateral opening section which extends inwardly in the lateral direction from an outer side of the rigid outer side area in which the shaft can be displaced essentially in the lateral direction. A cam (52) which is arranged in the base area of the outer side has a cam contour which is designed in such a manner that when mounting the outer wall in the position relative to a bearing surface device arranged on the rigid outer wall area, the shaft is inwardly displaced in the lateral opening section.
Patent NZ-599679-A (NZ)
Title: Mask system
Inventor: EVES MATTHEW
IPC: A61M16/06
Filed: 2010-09-10
Abstract: A mask system including a cushion adapted to seal with a face of a patient is disclosed. The mask could be used in a CPAP system. In one form an unobtrusive full-face masks system is provided which is comfortable and has a wide fit range. The mask system is constructed and arranged to be used on the person without requiring a forehead support. The mask system including a cushion, said cushion adapted to form a seal on the face of the patient in a nasal bridge region of the face, a side of nose region of the face, a mouth corner region of the face and a lip region of the face. The cushion is also forms a seal on the nasal bone of the nasal bridge region of a face below the nasion and above the cartilage of the nose. The cushion also includes at least one lateral stabilising portion adapted to direct a force against the side of the nose in the region of the nasal bridge. The cushion may include a sealing structure and a supporting structure. The supporting structure may include gaps or spacing in a nasal bridge region (NBR) and/or a lip region (CHN).
Patent NZ-608181-A (NZ)
Title: Automated apparatus for constructing assemblies of building components
Inventor: WILLIAMS JEFFREY P
IPC: B27F7/02
Filed: 2011-09-27
Abstract: Disclosed is a system for constructing wall panels comprising a plurality of structural members. The system comprises a source of structural members (400), a horizontal table (110), an articulated arm unit (300), at least one first clamping unit, at least one second clamping unit and a controller (500). The source of structural members may comprise wooden boards of predetermined size as the structural members. The horizontal table (110) is configured to support planks as they are being formed into a wall panel. The table includes a stationary section (120) and a movable carriage (170). The moveable carriage is configured to move in a longitudinal direction toward and away from the stationary section. The articulated arm unit (300) has a gripper (200). The articulating arm unit is positioned to retrieve boards from the source with the gripper and place them on the table. The first clamping unit(s) are mounted to the stationary section for clamping structural members thereto. The second clamping unit(s) are mounted to the movable carriage for clamping structural members thereto. The controller (500) controls the movement of the articulating arm unit and the movable carriage.
Patent NZ-618129-A (NZ)
Title: Compositions of humanized notch fusion proteins and methods of treatment
Inventor: KITAJEWSKI JAN
IPC: C07K16/46
Filed: 2008-08-22
Abstract: A fusion protein the sequence of which (a) is identical to the sequence of a portion of the extracellular domain of a human Notch4 receptor followed by (b) a sequence identical to the sequence of an Fc portion of an antibody, wherein the sequence of the portion of the extracellular domain of the human Notch4 receptor is a sequence selected from the group consisting of the sequences of EGF-like repeats 1-13, EGF-like repeats 1-23, EGF-like repeats 9-23, EGF-like repeats 9-29, EGF-like repeats 13-23 and EGF-like repeats 21-29, wherein (b) is located to the carboxy terminal side of (a) and wherein (b) is attached to (a) either directly or by means of a linker sequence.